Hepatitis B Vaccine (Recombinant)
| Brand name | Recombivax, Recombivax Hb |
|---|---|
| Active ingredient | Hepatitis B Vaccine (Recombinant) |
| Strength | 5UG/0.5ML |
| Dosage form | Injection |
| Route | Intramuscular |
| Modality | Biologic |
| FDA approval | July 1986 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.